Ten of the world’s largest pharmaceutical companies said on Wednesday that they would cooperate on research aimed at accelerating drug development, starting with streamlining clinical trials.
Pharmaceutical companies have collaborated before on areas considered not directly competitive, such as finding variants in the human genome and biomarkers to predict disease and the effectiveness of drugs. But the people behind the new effort said it would be the largest of its kind.
Read the full story: http://nyti.ms/UjLqhc
Source: The New York Times